Dr. Bruno Felipe Dantas, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-2147 |
Seyit Adil Can Iii, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-2147 Fax: 609-441-2107 |
Dr. William Upton Todd Iv, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8063 Fax: 609-441-2107 |
Zhiyong Ren, M.D., PHD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8063 |
Marianne Hamel, M.D., PH.D. Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Convention Blvd Ste 2, #361, Atlantic City, NJ 08401 Phone: 609-225-4865 |
Khosrow Rastgar, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-2147 Fax: 609-441-2107 |
News Archive
Cardiovascular disease remains the No. 1 cause of death in the U.S. Evidence suggests that elevated levels of triglycerides (fats) in the blood after meals, known as postprandial lipemia (PPL), is associated with an increased risk for hardening of the arteries—a risk factor for cardiovascular disease.
Exercise therapy improves mental health and cardiovascular fitness in patients with schizophrenia, researchers report.
Lymphedema, a chronic swelling condition common in breast cancer survivors, affects three million people in the U.S. In the past, most people believed that exercise might induce or worsen lymphedema. After reviewing the literature, University of Missouri researchers say the benefits of exercise outweigh the risks for breast cancer survivors and patients with lymphedema.
Laxai Pharma Ltd., an international pharmaceutical contract research organization, recently reached an agreement with UTA Capital LLC to extend the terms of an existing secured promissory note issued by the Company in favor of UTA on March 3, 2010 in the aggregate principal amount of $1.44 million ("Note").
› Verified 8 days ago